Emille Tejo Viana

Emille Tejo Viana

Auto-generated profile, based on publicly available information

Emille Tejo Viana

Universidade Anhembi Morumbi. Faculdade de Medicina. São Paulo - SP - Brasil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
Carlos Rocha OliveiraCarlos Rocha Oliveira
Carlos Rocha Oliveira
EVEmille Tejo Viana
Emille Tejo Viana
TGThaina Ferreira Gonçalves
Thaina Ferreira Gonçalves
JSJosé Roberto Mateus da Silva
José Roberto Mateus da Silva
Rodolfo P VieiraRodolfo P Vieira
Rodolfo P Vieira
The oxidative stress caused by systemic inflammatory response syndrome (SIRS), septic shock, and sepsis, is a risk factor triggering an increase in mortality in patients diagnosed with these pathologies. Selenium (Se) is an essential mineral that has antioxidant and cytoprotective functions, being strongly associated with the proper functioning of intracellular metabolic processes. In this context, the present study aims to investigate de therapeutic effects of intravenous selenium use considering pathologies such as SIRS, septic shock, sepsis, acute respiratory distress syndrome (ARDS), ventilator associated pneumonia (VAP), and coronavirus disease (COVID-19). This is an narrative literature review in which six main articles found in databases of SciELO, PubMed, and Google Scholar, were selected and analyzed. As a result, articles were found evidencing the benefit of Se in the inflammatory response, increasing the GPx-3 activity and decreasing the inflammatory cytokines, in addition to generating a lower risk of VAP, shortening the hospitalization time, and mortality. Thus, Se supplementation has beneficial evidence for acute respiratory diseases and should be considered as a viable option as adjuvant therapy.

31 May 2022 in Arquivos Médicos dos Hospitais e da Faculdade de Ciências Médicas da Santa Casa de São Paulo
Verified
Journal Article
Open access
PDF file
EVEmille Tejo Viana
Emille Tejo Viana
JKJulia Kelman
Julia Kelman
MPMarina Gravina Pereira
Marina Gravina Pereira
Carlos Rocha OliveiraCarlos Rocha Oliveira
Carlos Rocha Oliveira
Introdução: O estado inflamatório crônico e as alterações hormonais causadas pela Síndrome do Ovário Policístico são fatores que, somados à resistência insulínica e a hiperinsulinemia compensatória, complicam ainda mais o estado dessas pacientes. Por outro lado, estudos indicam que o uso de simbióticos – probióticos e prebióticos - podem reduzir os índices glicêmicos e a resistência insulínica. Objetivos: analisar artigos prévios que investigassem o uso de cápsulas simbióticas para a melhora do perfil insulínico, fatores inflamatórios e biomarcadores de estresse oxidativo em pacientes com SOP. Material e Método: Esta revisão selecionou cinco artigos principais encontrados nas bases de dados Scielo, PubMed e Google Acadêmico. Resultados: Evidenciou-se o benefício do uso de simbióticos na redução da resistência insulínica, níveis de insulina sérica, glicose plasmática, índices QUICK e HOMAR-IR e apelina-36. Conclusão: A suplementação com cápsulas simbióticas sustenta evidências benéficas para o tratamento da SOP e deve ser considerada uma como opção de terapia adjuvante, uma vez que auxilia no prognóstico dessa afecção.   Palavras-chave: Síndrome do ovário policístico, Simbióticos, Microbiota, Resistência à insulina, Glicemia   Abstract Introduction: The chronic inflammatory state and also the hormonal changes caused by Polycystic Ovary Syndrome (PCOS) are factors that, added to insulin resistance and compensatory hyperinsulinemia, may complicate the condition of these patients. On the other hand, studies indicate that the use of symbiotics, including probiotics and prebiotics, can reduce glycemic indexes and insulin resistance. Objective: The present review aimed to analyze previous works investigating the symbiotic capsules usage for improving insulin profile, inflammatory factors, and oxidative stress biomarkers in patients with PCOS. Methods: This review selected five main articles found in Scielo, PubMed, and Google Academic databases. Results: it was clear the benefits of the use of symbiotics in reducing insulin resistance, serum insulin levels, plasma glucose, QUICK, and HOMAR-IR indexes, and apelin-36. Conclusion: supplementation with symbiotic capsules supports beneficial evidence for the treatment of PCOS and should be considered as an adjuvant therapy option, once it helps the prognosis of this disease.  Key words: Polycystic ovary syndrome, Symbiotics, Microbiota, Insulin resistance, blood glucose